These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3316309)

  • 1. Comparison of the antihypertensive efficacy and adverse reactions to two doses of bendrofluazide and hydrochlorothiazide and the effect of potassium supplementation on the hypotensive action of bendrofluazide: substudies of the Medical Research Council's trials of treatment of mild hypertension: Medical Research Council Working Party.
    J Clin Pharmacol; 1987 Apr; 27(4):271-7. PubMed ID: 3316309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects.
    Carlsen JE; Køber L; Torp-Pedersen C; Johansen P
    BMJ; 1990 Apr; 300(6730):975-8. PubMed ID: 2344503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of bendroflumethiazide/potassium chloride versus hydrochlorothiazide/amiloride on blood pressure and serum electrolytes in patients with mild to moderate hypertension seen in general practice.
    Jørgensen F; Bredesgaard P; Johansen P
    Pharmatherapeutica; 1986; 4(10):655-64. PubMed ID: 3602017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrochlorothiazide and bendroflumethiazide in low doses--a comparative trial.
    Acta Pharmacol Toxicol (Copenh); 1984; 54 Suppl 1():47-51. PubMed ID: 6369883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension.
    Harper R; Ennis CN; Sheridan B; Atkinson AB; Johnston GD; Bell PM
    BMJ; 1994 Jul; 309(6949):226-30. PubMed ID: 7818648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate.
    Peterzan MA; Hardy R; Chaturvedi N; Hughes AD
    Hypertension; 2012 Jun; 59(6):1104-9. PubMed ID: 22547443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrochlorothiazide and potassium chloride in comparison with hydrochlorothiazide and amiloride in the treatment of mild hypertension.
    Andersen B; Snorrason SP; Ragnarsson J; Hardarson T
    Acta Med Scand; 1985; 218(5):449-54. PubMed ID: 3911735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension.
    Lancet; 1981 Sep; 2(8246):539-43. PubMed ID: 6115999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of antihypertensive treatment on quality of life: comparison between bisoprolol and bendrofluazide.
    Vanmolkot FH; de Hoon JN; van de Ven LL; Van Bortel LM
    J Hum Hypertens; 1999 Aug; 13(8):559-63. PubMed ID: 10455479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of enalapril and bendrofluazide for treatment of systemic hypertension.
    Zezulka AV; Gill JS; Dews I; Joy MD; Beevers DG
    Am J Cardiol; 1987 Mar; 59(6):630-3. PubMed ID: 3030087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular extrasystoles during thiazide treatment: substudy of MRC mild hypertension trial.
    Br Med J (Clin Res Ed); 1983 Oct; 287(6401):1249-53. PubMed ID: 6196073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized comparison of a conventional dose, a low dose and alternate-day dosing of bendrofluazide in hypertensive patients.
    Girvin B; Johnston GD
    J Hypertens; 1998 Jul; 16(7):1049-54. PubMed ID: 9794747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of diuretic and beta-blocker therapy in the Medical Research Council Trial.
    Greenberg G; Brennan PJ; Miall WE
    Am J Med; 1984 Feb; 76(2A):45-51. PubMed ID: 6702863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertension.
    Wilcox RG; Mitchell JR
    Br Med J; 1977 Aug; 2(6086):547-50. PubMed ID: 329948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verapamil and bendrofluazide in the treatment of hypertension: a controlled study of effectiveness alone and in combination.
    Benjamin N; Phillips RJ; Robinson BF
    Eur J Clin Pharmacol; 1988; 34(3):249-53. PubMed ID: 3294021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indapamide and bendrofluazide: a comparison in the management of essential hypertension.
    Bing RF; Russell GI; Swales JD; Thurston H
    Br J Clin Pharmacol; 1981 Dec; 12(6):883-6. PubMed ID: 7041937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of long acting diltiazem (Tildiem LA) with sustained release nifedipine (nifedipine SR) and bendrofluazide in the treatment of mild to moderate hypertension.
    Hosie J; Nasar MA; Belgrave GP; Walters EG
    Acta Cardiol; 1994; 49(3):251-65. PubMed ID: 7941918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the acute effects of cicletanine and bendrofluazide on urinary electrolytes and plasma potassium in essential hypertension.
    Singer DR; Markandu ND; Sugden AL; MacGregor GA
    Eur J Clin Pharmacol; 1990; 39(3):227-32. PubMed ID: 2257857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypotensive effects of xipamide in essential hypertension. Crossover comparison with hydrochlorothiazide.
    Pasquel R; Tribble PW; Simon A
    J Clin Pharmacol; 1981 Jul; 21(7):316-22. PubMed ID: 7021608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure lowering and potassium conservation by triamterene-hydrochlorothiazide and amiloride-hydrochlorothiazide in hypertension.
    Maxwell MH; Brachfeld J; Itskovitz H; Lunn JA; Moser M; Zawada ET
    Clin Pharmacol Ther; 1985 Jan; 37(1):61-5. PubMed ID: 3880686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.